Home
About
Overview
Sharing Data
ORCID
Help
History (11)
Low dose tPA plus annexin A2 combination attenuates tPA delayed treatment-associated hemorrhage and improves recovery in rat embolic focal stroke.
Home-Delivered Meals and Risk of Self-Reported Falls: Results From a Randomized Trial.
Auto-antibody production and glomerulonephritis in congenic Slamf1-/- and Slamf2-/- [B6.129] but not in Slamf1-/- and Slamf2-/- [BALB/c.129] mice.
Intercalated erlotinib-docetaxel dosing schedules designed to achieve pharmacodynamic separation: results of a phase I/II trial.
Pharmacologic interventions for type 1 and type 2 diabetes.
See All 11 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Pharmacologic interventions for type 1 and type 2 diabetes.
Fain JA, Miller DK. Pharmacologic interventions for type 1 and type 2 diabetes. Nurs Clin North Am. 2006 Dec; 41(4):589-604, vii.
View in:
PubMed
subject areas
Diabetes Mellitus, Type 1
Diabetes Mellitus, Type 2
Drug Therapy, Combination
Humans
Hypoglycemic Agents
authors with profiles
James Allen Fain PhD, RN, BC-ADM, FAAN